RADNOR, Pa. — Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, today announced that Corey Walker has rejoined the company as President of Avantor’s Laboratory Solutions business, reporting to CEO Michael Stubblefield. “Corey’s deep knowledge of our end markets and industry, […]
WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”), a leading global life sciences and diagnostics innovator, today announced that Julie Sawyer Montgomery will succeed Joakim Weidemanis as Executive Vice President, Diagnostics effective as of July 1, 2024. Mr. Weidemanis will support the transition over the next three months and will retire from Danaher […]
INTEGRA Biosciences is excited to welcome Line Stigen Raquet as a non-executive board member. Line has over 20 years’ leadership experience in the life sciences sectors, and her extensive business knowledge will contribute to INTEGRA’s continued growth. Line is a biochemist by education and training, giving her a firm foundation for success as an entrepreneur […]
Tony J. Hunt to Transition from Chief Executive Officer to Executive Chair, Olivier Loeillot Appointed to Role of President and Chief Executive Officer, Effective September 1, 2024 WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that its Board of Directors (“Board”) has approved the planned transition […]
Cunningham previously served as CCO for Exact Sciences and brings more than20 years of commercial leadership across healthcare tech, life sciences, and pharma SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the appointment of Everett Cunningham as Chief Commercial Officer (CCO), effective June 10. Cunningham will be responsible […]
Move reflects increasing investment in AI as driving force for innovation and productivity. Company will host Innovation Summit in December focused on AI in R&D. WASHINGTON — Danaher Corporation (NYSE: DHR), a global science and technology innovator, today announced the creation of the new role of Chief Data & Artificial Intelligence (AI) Officer and the […]
LGC has today announced that Marcus Kaeller will join its Board of Directors and Executive Leadership Team (ELT) as Chief Financial Officer (CFO), effective 3rd June 2024. Marcus succeeds Vivid Sehgal, who will leave LGC after almost two and a half years of service. Over the past several months, Vivid has worked closely with the LGC […]
BRANFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Charles (“Chuck”) Kummeth to the role of independent Chairman of the Board, effective May 27, 2024. Mr. Kummeth has over 35 years of leadership experience in Life Sciences most recently as President and CEO of Bio-Techne. During […]
MARLBOROUGH, Mass. — Bringing a wealth of experience and strategic acumen garnered from a storied career in the life sciences, Mike Stapleton’s appointment fortifies Scitara’s leadership team. With a remarkable trajectory spanning various leadership roles across software, consumables, instruments and services, consulting, and pharmaceutical domains, Mike is renowned for his trailblazing contributions to industry transformation. […]
Life Sciences Veteran Joins To Accelerate Company Growth Amsterdam, the Netherlands – LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity analysis, today announced that Hugo de Wit has been appointed Chief Executive Officer, based in the Company’s headquarters in Amsterdam. Olivier Heyning, the previous CEO of LUMICKS, said, “After leading […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
